Your browser doesn't support javascript.
loading
In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Barman-Aksözen, Jasmin; Minder, Elisabeth I; Schubiger, Carina; Biolcati, Gianfranco; Schneider-Yin, Xiaoye.
Affiliation
  • Barman-Aksözen J; Institute of Laboratory Medicine, Triemli Hospital, Zürich, Switzerland.
  • Minder EI; Institute of Laboratory Medicine, Triemli Hospital, Zürich, Switzerland.
  • Schubiger C; Institute of Laboratory Medicine, Triemli Hospital, Zürich, Switzerland.
  • Biolcati G; Porphyria Center, San Gallicano Dermatologic Institute IRCCS, Rome, Italy.
  • Schneider-Yin X; Institute of Laboratory Medicine, Triemli Hospital, Zürich, Switzerland. Electronic address: xiaoye.schneider@triemli.zuerich.ch.
Blood Cells Mol Dis ; 54(1): 71-7, 2015 Jan.
Article in En | MEDLINE | ID: mdl-25179834
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protoporphyrins / Gene Expression Regulation, Enzymologic / Protoporphyria, Erythropoietic / Erythrocytes / 5-Aminolevulinate Synthetase / Iron Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Cells Mol Dis Journal subject: HEMATOLOGIA Year: 2015 Document type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protoporphyrins / Gene Expression Regulation, Enzymologic / Protoporphyria, Erythropoietic / Erythrocytes / 5-Aminolevulinate Synthetase / Iron Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Cells Mol Dis Journal subject: HEMATOLOGIA Year: 2015 Document type: Article Affiliation country: Switzerland